Expert Panel: Digital Solutions for Behavioral Health
Expert Panel Discussion: Digital Solutions for Behavioral Health
Attend an expert panel discussion that highlights the role of digital health solutions and modalities for behavioral health patients, the care delivery organizations that serve them, and the managed care organizations and payers that manage their benefits.
• Physical and Behavioral Health Practitioners or Practices.
• Health Plans.
• Managed Care Organizations.
• Managed Behavioral Healthcare Organizations.
• Population Health Organizations.
• Employer Organizations.
• Learn about solutions that go beyond remotely delivering traditional behavioral health care by supporting patients’ and providers’ goals to prevent, manage, and treat behavioral health conditions.
• Better understand how digital health solutions fit into the care continuum for behavioral health patients.
• Learn how digital behavioral health solutions have an ability to improve patient engagement, quality of care, and outcomes.
• Discuss how digital health solutions have the ability to remove some of the biggest access barriers for behavioral healthcare—and create new ones.
Brad Ryan, MD
Dr. Brad Ryan is NCQA’s first Chief Product Officer. His addition to NCQA leadership signals the organization’s commitment to build on its existing quality measurement expertise with the promise of new technology, digital measurement and telehealth. He leads NCQA’s pioneering work in digital quality transformation and manages growth and evolution of its existing health care measurement, evaluation and improvement programs.
Dr. Ryan’s prior work includes numerous assists with NCQA’s digital quality initiatives, most recently as co-founder and Chief Solutions & Product Officer at Apervita, a collaborative platform for value-based health care. He also supported NCQA’s Natural Language Processing work with UPMC Enterprises. Dr. Ryan’s professional background is a “perfect storm” of skills and experience for the newly created position. In addition to Apervita, Brad has held leadership roles at IMS Health and McKinsey & Company.
Dr. Ryan earned his medical degree at John’s Hopkins School of Medicine. He studied engineering, computer science and mathematics as an undergraduate at the University of Alabama. To this day, he remains firmly committed to “Roll Tide” and to his family and friends in Alabama.
Megan Jones Bell, Psy.D.
Dr. Megan Jones Bell is Chief Strategy and Science Officer at Headspace, a leader in the field of digital health and a visionary in making mental health care more effective, affordable and accessible globally. She was previously Chief Science Officer and scientific founder at Lantern and Assistant Clinical Professor in Psychiatry and Behavioral Sciences at Stanford University.
Dr. Jones Bell earned her bachelor’s degree in Psychology, graduating cum laude from the University of California, San Diego. She received her master’s degree and doctorate in Clinical Psychology from PGSP-Stanford University and completed fellowships in Child and Adolescent Psychology at Yale University and Stanford University School of Medicine.
Dr. Yuri Maricich, MD, MBA
Dr. Maricich is the Chief Medical Officer and Head of Development at Pear Therapeutics, and is a licensed, board-certified physician, investor, clinical developer and strategist. He works to improve patient health and our health care system by investing in, advising and providing leadership at innovative firms. At Pear Therapeutics, he leads the Clinical, Regulatory and Quality groups as the Chief Medical Officer and Head of Development. He leads and manages the development programs from Discovery/TPP stage through Translational, Clinical Development, Regulatory submission and review, as well as Medical Affairs. In addition to overseeing subsequent pipeline programs across a broad-spectrum of disease areas, he has led the reSET, reSET-O and Somryst programs.
Prior to joining Pear, Dr. Maricich worked with and led successful teams and programs at Healthcare & Life Science/biotech (HLS) firms, including Corixa (acquired by GlaxoSmithKline), Xdynia (acquired by Cavion), Cavion (acquired by Jazz Pharmaceuticals) and AWS. While a med student, he founded a digital health firm that used AI and NLP to structure clinical data.
Dr. Maricich completed his education and training at Harvard University, the University of Washington, the University of Notre Dame and the University of Virginia.
- 1.00 Participation